Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

PPH Market Vectors Pharmaceutical ETF

  • Fund Description

    Market Vectors® Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

  •  
      

    • Fund Ticker

      PPH
    • Exchange

      NASDAQ
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVPPHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 05/06/16

    • 30-Day SEC Yield1

      1.54%
    • Total Net Assets

      $238.8M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.41%
    • Net Expense Ratio/TER2

      0.36%
    • Distribution Frequency

      Quarterly
    • Next Distribution Date

      06/30/2016
  • Portfolio Composition (%)
    as of 05/06/16

    • % of Net Assets
    • Stocks

      100.08
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      -0.08
  • Download All HoldingsDaily Holdings (%) as of 05/06/16

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Pfizer Inc
    PFE US
    420,834
    14,131,6065.92
    Abbvie Inc
    ABBV US
    221,946
    13,873,8445.81
    Bristol-Myers Squibb Co
    BMY US
    190,961
    13,600,2425.70
    Johnson & Johnson
    JNJ US
    117,148
    13,207,2665.53
    Glaxosmithkline Plc
    GSK US
    313,045
    13,188,5865.52
    Merck & Co Inc
    MRK US
    239,029
    12,811,9545.36
    Novartis Ag
    NVS US
    172,818
    12,624,3555.29
    Shire Plc
    SHPG US
    70,808
    12,306,4305.15
    Sanofi
    SNY US
    311,023
    12,114,3465.07
    Novo Nordisk A/S
    NVO US
    224,938
    12,000,4425.03
    Mckesson Corp
    MCK US
    69,582
    11,749,6174.92
    Zoetis Inc
    ZTS US
    243,302
    11,517,9174.82
    Eli Lilly & Co
    LLY US
    153,170
    11,426,4824.78
    Abbott Laboratories
    ABT US
    286,767
    10,888,5434.56
    Astrazeneca Plc
    AZN US
    384,700
    10,756,2124.50
    Teva Pharmaceutical Industries Ltd
    TEVA US
    194,543
    9,779,6774.10
    Allergan Plc
    AGN US
    43,160
    8,703,2143.64
    Amerisourcebergen Corp
    ABC US
    99,295
    7,598,0533.18
    Mylan Nv
    MYL US
    186,106
    7,379,1033.09
    Perrigo Co Plc
    PRGO US
    75,336
    6,960,2932.91
    Valeant Pharmaceuticals International I
    VRX US
    168,476
    5,035,7482.11
    Jazz Pharmaceuticals Plc
    JAZZ US
    20,959
    3,025,4321.27
    Mallinckrodt Plc
    MNK US
    41,763
    2,355,4330.99
    Endo International Plc
    ENDP US
    72,042
    1,164,9190.49
    Akorn Inc
    AKRX US
    36,936
    812,5920.34
    Other/Cash
    --
    --
    -202,973-0.08
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.